Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2023-05-15
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
- Others nearbySan Francisco, CA
$170.7m
reported value
-24.0% vs Q4 2022
11positions
97.4%in top 10
0 new
3 added
5 reduced
1 sold out
vs Q4 2022
Options: 0 call positions (— notional), 1 put positions ($70.6m notional) – listed below, not included above.
Holdings, Q1 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BLUEPRINT MEDICINES CORP BPMC | $28.0m16.42% | Added +41.1k |
| ARROWHEAD PHARMACEUTICALS IN ARWR | $25.9m15.16% | Reduced -85.0k |
| MERUS N V MRUS | $22.5m13.21% | Reduced -207.0k |
| KYMERA THERAPEUTICS INC KYMR | $17.8m10.44% | Reduced -28.1k |
| ARVINAS INC ARVN | $17.2m10.07% | Reduced -45.0k |
| REGENXBIO INC RGNX | $15.7m9.21% | Reduced -66.7k |
| UNIQURE NV QURE | $12.8m7.52% | Added +12.7k |
| GENMAB A/S GMAB | $9.2m5.37% | Unchanged |
| ARGENX SE ARGX | $8.9m5.24% | Unchanged |
| SILENCE THERAPEUTICS PLC SLN | $8.1m4.77% | Added +28.1k |
| PIERIS PHARMACEUTICALS INC COM | $4.4m2.60% | Unchanged |
Sold out since Q4 2022
| Security | Value then |
|---|---|
| AMRYT PHARMA PLC | $15.3m2.1m shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| INVESCO QQQ TR QQQ · Put | $70.6m220.0k shares | New |